Integrating large scale genetic and clinical information to predict cases of heart failure

Kuan-Han H Wu1, Brooke N Wolford2, Jiacong Du3

  • 1Department of Computational Medicine and Bioinformatics, University of Michigan, Ann Arbor, MI, USA.

Communications Medicine
|November 22, 2025
PubMed

Insights

Integrating genetic and electronic health record risk scores significantly improves early heart failure prediction. This combined approach enhances risk identification years before diagnosis, enabling timely interventions.

Area of Science:

  • Genetics and Genomics
  • Cardiovascular Disease Epidemiology
  • Health Informatics

Background:

  • Heart failure (HF) is a leading global cause of mortality.
  • Early identification of individuals at risk for HF is crucial for effective intervention.
  • Existing prediction models may not fully leverage diverse data sources.

Purpose of the Study:

  • To enhance heart failure (HF) prediction accuracy by integrating polygenic risk scores (PRS) from genome-wide association studies (GWAS) and clinical risk scores (ClinRS) derived from electronic health records (EHR).
  • To evaluate the performance of combined PRS and ClinRS against individual scores and existing HF risk models.

Main Methods:

  • Developed a PRS from a large HF GWAS.
  • Created a ClinRS using natural language processing and LASSO regression on EHR data from three Michigan Medicine cohorts.
  • Compared the predictive performance of baseline models, PRS, ClinRS, and a combined ClinRS+PRS model using logistic regression.
  • Validated models against the Atherosclerosis Risk in Communities (ARIC) HF risk score.

Main Results:

  • Both PRS and ClinRS significantly improved HF prediction compared to baseline models, up to eight years pre-diagnosis.
  • The combined ClinRS+PRS model enhanced prediction performance up to ten years pre-diagnosis, two years earlier than individual scores.
  • ClinRS demonstrated superior performance over the ARIC HF risk score one year prior to diagnosis.

Conclusions:

  • Integrating GWAS-derived PRS and EHR-derived ClinRS offers additive predictive power for identifying individuals at risk of heart failure before clinical diagnosis.
  • This standardized and scalable risk prediction tool holds potential for facilitating earlier physician interventions and improving patient outcomes.
Abstract

Related Concept Videos

Heart Failure IV: Classification and Diagnostic Evaluation01:30

Heart Failure IV: Classification and Diagnostic Evaluation

Heart failure can be classified in various ways, with the most common classifications based on physical activity limitations, disease progression, severity, and treatment strategies.The Functional Classification of Heart Failure divides patients into four categories based on physical activity limitation due to symptom burden.Class I: Patients in this class have cardiac disease but no physical activity limitations. Ordinary activities like walking, climbing stairs, or routine tasks do not cause...
300
Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
2.7K
Genome-wide Association Studies-GWAS01:11

Genome-wide Association Studies-GWAS

Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
15.2K
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
693
Heart Failure I: Introduction01:27

Heart Failure I: Introduction

Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...
671
Heart Failure III: Clinical Manifestations01:26

Heart Failure III: Clinical Manifestations

Heart failure (HF) manifests primarily as dyspnea, fatigue, and fluid retention, resulting in peripheral and pulmonary edema. Symptoms may vary depending on which ventricle is more affected, left or right.Left-Sided Heart FailureAlso known as left ventricular failure, this condition results from the left ventricle's inability to fill or eject sufficient blood into the systemic circulation. It leads to pulmonary congestion, which occurs when the left ventricle fails to eject blood effectively...
452